Andra Ap Fonden Biomarin Pharmaceutical Inc Transaction History

Andra Ap Fonden

$6.64 Billion
Q3 2024

A detailed history of Andra Ap Fonden transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Andra Ap Fonden holds 23,200 shares of BMRN stock, worth $1.52 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

23,200

Previous 18,400 26.09%

Holding current value

$1.52 Million

Previous $1.51 Million 7.66%

% of portfolio

0.02%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$69.02 - $93.84 $331,296 - $450,432	4,800 Added 26.09%	23,200 $1.63 Million
Q2 2024 Aug 07, 2024	BUY	$74.43 - $92.22 $1.37 Million - $1.7 Million	18,400 New	18,400 $1.51 Million
Q4 2023 Feb 15, 2024	SELL	$76.22 - $98.51 $640,248 - $827,484	-8,400 Reduced 14.53%	49,400 $4.76 Million
Q3 2023 Nov 09, 2023	SELL	$85.07 - $94.48 $1.23 Million - $1.36 Million	-14,400 Reduced 19.94%	57,800 $5.11 Million
Q2 2023 Aug 09, 2023	SELL	$86.68 - $100.3 $1.45 Million - $1.68 Million	-16,700 Reduced 18.79%	72,200 $6.26 Million
Q1 2023 May 12, 2023	BUY	$87.74 - $117.27 $973,914 - $1.3 Million	11,100 Added 14.27%	88,900 $8.64 Million
Q4 2022 Feb 13, 2023	SELL	$80.93 - $108.63 $1.25 Million - $1.67 Million	-15,400 Reduced 16.52%	77,800 $8.05 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $525,824 - $620,416	6,400 Added 7.37%	93,200 $7.9 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $543,248 - $660,060	7,600 Added 9.6%	86,800 $7.19 Million
Q4 2021 Feb 15, 2022	SELL	$71.72 - $91.47 $1.96 Million - $2.5 Million	-27,300 Reduced 25.63%	79,200 $7 Million
Q3 2021 Nov 12, 2021	BUY	$74.77 - $85.47 $119,632 - $136,752	1,600 Added 1.53%	106,500 $8.23 Million
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $1.19 Million - $1.34 Million	15,800 Added 17.73%	104,900 $8.75 Million
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $567,948 - $689,244	-7,600 Reduced 7.86%	89,100 $6.73 Million
Q4 2020 Feb 12, 2021	BUY	$72.61 - $90.2 $4.56 Million - $5.66 Million	62,800 Added 185.25%	96,700 $8.48 Million
Q3 2020 Nov 12, 2020	SELL	$71.87 - $131.03 $1.28 Million - $2.33 Million	-17,800 Reduced 34.43%	33,900 $2.58 Million
Q2 2020 Aug 06, 2020	BUY	$79.55 - $124.22 $1.07 Million - $1.66 Million	13,400 Added 34.99%	51,700 $6.38 Million
Q1 2020 May 13, 2020	BUY	$71.37 - $96.85 $892,125 - $1.21 Million	12,500 Added 48.45%	38,300 $3.24 Million
Q4 2019 Feb 10, 2020	BUY	$64.27 - $86.37 $469,171 - $630,501	7,300 Added 39.46%	25,800 $2.18 Million
Q2 2019 Aug 15, 2019	SELL	$80.35 - $93.9 $120,524 - $140,850	-1,500 Reduced 7.5%	18,500 $1.59 Million
Q1 2019 May 14, 2019	BUY	$84.2 - $98.62 $1.68 Million - $1.97 Million	20,000 New	20,000 $1.78 Million
Q2 2018 Aug 17, 2018	SELL	$76.01 - $99.03 $744,898 - $970,494	-9,800 Closed	0 $0
Q1 2018 Apr 10, 2018	BUY	$77.67 - $92.63 $761,166 - $907,774	9,800 New	9,800 $794,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Andra Ap Fonden with notifications on news.

Account